Inventor · disambiguated record
Anthony F. Hadfield
Also filed as: HADFIELD ANTHONY · HADFIELD ANTHONY F · HADFIELD ANTHONY FRANCIS
14 granted patents·5 pending applications·238 citations·filing 2002–2017
93Inventor score
Top patents by PatentIndex Score
19 records- 0194US6673838B2Succinate salt of O-desmethyl-venlafaxineWYETH CORP·Filed 2002·Granted Jan 6, 2004·112 cites·46 claims
- 0292US7514466B2Purification of progesterone receptor modulatorsWYETH CORP·Filed 2005·Granted Apr 7, 2009·23 cites·29 claims
- 0391US8022216B2Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereofWYETH LLC·Filed 2008·Granted Sep 20, 2011·14 cites·4 claims
- 0490US7291347B2Succinate salt of O-desmethyl-venlafaxineWYETH CORP·Filed 2006·Granted Nov 6, 2007·21 cites·9 claims
- 0589US8394959B2Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-2-buteramide and crystalline forms thereofLU QINGHONG·Filed 2012·Granted Mar 12, 2013·14 cites·5 claims
- 0689US8173814B2Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereofLU QINGHONG·Filed 2011·Granted May 8, 2012·13 cites·4 claims
- 0788US9139558B2Maleate salts of (E)-N-{4-[3-Chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereofWYETH LLC·Filed 2013·Granted Sep 22, 2015·9 cites·20 claims
- 0886US9630946B2Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereofWYETH LLC·Filed 2015·Granted Apr 25, 2017·5 cites·16 claims
- 0983US8609712B2Purification of progesterone receptor modulatorsWILK BOGDAN KAZIMIERZ·Filed 2012·Granted Dec 17, 2013·6 cites·21 claims
- 1082US8309594B2Purification of progesterone receptor modulatorsWILK BOGDAN KAZIMIERZ·Filed 2009·Granted Nov 13, 2012·5 cites·21 claims
- 1179US8372995B2Crystalline solid forms of tigecycline and methods of preparing sameWYETH LLC·Filed 2006·Granted Feb 12, 2013·4 cites·10 claims
- 1279US7001920B2Formate salt of O-desmethyl-venlafaxineWYETH CORP·Filed 2003·Granted Feb 21, 2006·10 cites·47 claims
- 1377US7154001B2Formate salt of O-desmethyl-venlafaxineWYETH CORP·Filed 2005·Granted Dec 26, 2006·2 cites·7 claims
- 1464US10035788B2Maleate salts of (E)-N-{4[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereofWYETH LLC·Filed 2017·Granted Jul 31, 2018·0 cites·24 claims
- 1560US2009018208A1Novel Succinate Salt of O-Desmethyl-VenlafaxineWYETH CORP·Filed 2007·Application pending·0 cites
- 1654US2004044241A1Novel succinate salt of O-desmethyl-venlafaxineWYETH CORP·Filed 2003·Application pending·0 cites
- 1752US2009192311A1Crystalline and amorphous 4-cyano-n--n-pyridin-2-yl-benzamide hydrochlorideBROWNE ERIC N C·Filed 2009·Application pending·0 cites
- 1846US2007027162A1Crystalline and amorphous 4-cyano-N-{(2R)-2-[4-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazin -1-yl]-propyl}-N-pyridin-2-yl-benzamide hydrochlorideWYETH CORP·Filed 2006·Application pending·0 cites
- 1941US2004103193A1Response time and resource consumption management in a distributed network environmentFiled 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →